Stryker Corp (SYK)
336.88
+1.97
(+0.59%)
USD |
NYSE |
Apr 24, 16:00
336.88
0.00 (0.00%)
After-Hours: 17:12
Stryker Cash from Operations (TTM): 3.711B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.711B |
September 30, 2023 | 3.186B |
June 30, 2023 | 3.025B |
March 31, 2023 | 2.866B |
December 31, 2022 | 2.624B |
September 30, 2022 | 2.621B |
June 30, 2022 | 2.665B |
March 31, 2022 | 3.014B |
December 31, 2021 | 3.263B |
September 30, 2021 | 3.50B |
June 30, 2021 | 3.396B |
March 31, 2021 | 3.138B |
December 31, 2020 | 3.277B |
September 30, 2020 | 2.775B |
June 30, 2020 | 2.575B |
March 31, 2020 | 2.469B |
December 31, 2019 | 2.191B |
September 30, 2019 | 2.502B |
June 30, 2019 | 2.491B |
March 31, 2019 | 2.626B |
December 31, 2018 | 2.61B |
September 30, 2018 | 2.243B |
June 30, 2018 | 1.704B |
March 31, 2018 | 1.705B |
December 31, 2017 | 1.559B |
Date | Value |
---|---|
September 30, 2017 | 1.538B |
June 30, 2017 | 1.961B |
March 31, 2017 | 1.804B |
December 31, 2016 | 1.915B |
September 30, 2016 | 2.01B |
June 30, 2016 | 999.00M |
March 31, 2016 | 863.00M |
December 31, 2015 | 981.00M |
September 30, 2015 | 907.00M |
June 30, 2015 | 1.94B |
March 31, 2015 | 1.953B |
December 31, 2014 | 1.782B |
September 30, 2014 | 1.775B |
June 30, 2014 | 1.873B |
March 31, 2014 | 1.859B |
December 31, 2013 | 1.886B |
September 30, 2013 | 1.81B |
June 30, 2013 | 1.757B |
March 31, 2013 | 1.858B |
December 31, 2012 | 1.657B |
September 30, 2012 | 1.688B |
June 30, 2012 | 1.565B |
March 31, 2012 | 1.265B |
December 31, 2011 | 1.434B |
September 30, 2011 | 1.324B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
2.191B
Minimum
Dec 2019
3.711B
Maximum
Dec 2023
2.910B
Average
2.866B
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Boston Scientific Corp | 2.503B |
Haemonetics Corp | 197.28M |
Abbott Laboratories | 7.261B |
Zimmer Biomet Holdings Inc | 1.582B |
Edwards Lifesciences Corp | 895.80M |